TG and metabolic dysfunction-associated steatohepatitis: Resmetirom (MGL-316) is one such thyroid hormone derivative with high affinity to thyroid hormone receptors (THRs) targeting the liver and was shown to be the most effective among other derivatives in the treatment of NASH in recent times.